Megha Cila

Megha Cila has a diverse range of work experience in the field of scientific research and development. Megha currently holds the position of Principal Scientist at Tune Therapeutics, starting in April 2023. Prior to this, they worked at Zymtronix as a Staff Scientist in R&D Chemistry from April 2022 to April 2023.

From 2018 to 2022, Megha was employed at Singular Genomics, where they held various roles. Megha began as a Scientist in March 2018 and transitioned to the position of Scientist II in May 2019. Megha then became a Senior Scientist in R&D Chemistry in February 2020 and held this position until April 2022.

Before their industry experience, Megha worked as a Postdoctoral Researcher at The Scripps Research Institute from August 2015 to March 2018. During this time, they made significant contributions to the field by discovering a new methodology for phosphorylation and synthesizing various compounds.

Furthermore, Megha has academic experience as a Graduate Research and Teaching Assistant at the University of Idaho from August 2010 to July 2015. Megha also gained research experience as a Summer Intern at the Indian Institute of Science Education and Research, Thiruvananthapuram in 2009.

Overall, Megha Cila has a strong background in scientific research and has demonstrated their expertise in various roles throughout their career.

Megha Cila completed their education in a chronological manner. Megha first attended Delhi University from 2005 to 2008, where they obtained a Bachelor of Science (B.Sc) degree in Chemistry. Megha then pursued a Master's degree from Delhi University from 2008 to 2010, specializing in Organic Chemistry. Additionally, they obtained an M.Sc degree from Delhi University during the same time period. Later, Megha attended the University of Idaho from 2010 to 2015, where they earned a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry. Following their Ph.D., they joined Scripps Research as a Postdoctoral Research Associate from 2015 to 2018, focusing on Organic Chemistry research.